Pharmaceutical sector's regulator National Pharmaceutical Pricing Authority (NPPA) has analysed bills of some hospitals and concluded that doctors and hospital prefer prescribing branded drugs, which are not under price control.
CNBC-TV18's Ekta Batra gives us more details about what all has the pharma regulator found in its analysis, and what are their recommendations to tackle those concerns.
KK Aggarwal, Former President of Indian Medical Association and Shailaja Chandra, Former Health Secretary for Delhi Government discussed the concerns at length.
For entire discussion, watch accompanying videos.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
